Trials / Completed
CompletedNCT01691430
A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents
A Randomized, Controlled Trial of Cranberry Capsules for UTI Prevention in Nursing Home Residents
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 185 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacteriuria plus pyuria in female nursing home residents. These aims will be accomplished by conducting a double blind randomized placebo controlled efficacy trial of two oral cranberry capsules daily versus placebo in a cohort of Connecticut female nursing home residents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 2 cranberry capsules | Two cranberry capsules qd (each capsule containing 36mg proanthocyanidin, total 72mg PAC) |
| DIETARY_SUPPLEMENT | Placebo | Two placebo capsules qd (each capsule containing 36mg proanthocyanidin, total 72mg PAC) |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2012-09-24
- Last updated
- 2020-03-06
- Results posted
- 2018-01-29
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01691430. Inclusion in this directory is not an endorsement.